Highlights in the Year 2005
10. 1. 2005 |
Lek, a Sandoz company, in cooperation with the Ministry of Health and the Ministry of Defense, donated medicines (antibiotics) to all affected by the natural disaster in south-east Asia through the Slovenian Red Cross in the total value of SIT 120 million. The contribution was supported by all Lek associates with the desire to help.
21. 1. 2005 |
Lek, a Sandoz company, received an award for effective advertising at the 2nd Slovene EFFIE Festival of Effective Communication, this time for the Angal campaign. Eight awards were given at the Festival. The committee assessed the campaign ‘Angal, double relief for a sore throat’ as an example of a successful new method of communication with the lay public by the pharmaceutical industry. The communicational and marketing objectives of the campaign were exceeded despite a tightly regulated and competitive pharmaceutical market.
25. 1. 2005 |
Lek, a Sandoz company, ended the year 2004 with SIT 127.6 million of revenues from sales, with a net profit of SIT 23.6 million, according to the Slovenian Accounting Standards. In the business center of central and eastern Europe, south west Europe and in the Community of Independent States for which Lek is responsible within the Sandoz group, the recorded sales were $478.5 million, which represents a 16.7% growth when compared to the previous year.
15. 2. 2005 |
Lek, a Sandoz company, donated SIT 3 million for the purchase of a ventilation system at the Transplant Center thereby contributing to the improvement of the working environment at the Pediatric Clinic and to the safer recovery of patients. The threat of bacterial infection, which can be extremely dangerous to patients, will be lower due to the new ventilation system.
Lek welcomes the newly appointed ambassador of the Russian Federation
15. 2. 2005 |
The CEO, Metod Dragonja, presented Lek’s business results for 2004 to the newly appointed ambassador of the Russian Federation in Slovenia, Mihail Velentinovich, and to the trade representative of the Russian Federation in Slovenia, Vjačeslav Nikolajevich, and emphasized the sales achieved on the Russian market, where Lek has strengthened its position. His Excellency Mihal Valentinovich Vanin emphasized the reform of the healthcare system in the Russian Federation, according to which available public funds for healthcare would be greater.
Lek receives an award for the best intranet
8. 3. 2005 |
At the first Slovenian conference about intranet and internal communication entitled ‘How to design and develop the intranet as a strategic business tool’, there was the competition INTRA in which Lek received an award for the best intranet in Slovenia. This was a joint award for a relatively wide circle of employees who began working on Lek’s intranet 10 years ago, for the whole team that participated in its remake in 2001 and for the administrators who regularly update it.
22. 3. 2005 |
Today, the supervisory Board of Lek, a Sandoz company, approved the appointment of Janja Bratoš as the CEO of Lek, who will assume management of Lek and all of Sandoz’s operations in Slovenia on April 1. With such an appointment, Sandoz is putting trust in Lek’s management and employees for a successful integration. In her 30-year career at Lek, Janja Bratoš achieved a number of noticeable business successes. She gained considerable experience in development and intellectual property. She managed Marketing and Sales through the complex and very successful establishment of its international operations, and since 1998, she supervised the Amoxiclav project and significantly contributed to its success on the US market.
Visit of the CEO of Novartis, Dr. Daniel Vasella
23. 3. 2005 |
During his visit to Slovenia, the CEO of Novartis met with the President of the Republic of Slovenia, Dr. Janez Drnovšek, and presented to reporters the Novartis’ business success and their principal guidelines. He was also the main guest at the working table on the management of business systems, which included the presidents of management and supervisory boards of international companies, and other important people in international business and politics.
Lek supports the Unicef Rag-doll project
25. 3. 2005 |
Under the slogan ‘Adopt a Doll and Save a Child’, the Unicef Rag-doll project was carried out in March 2005 in which Unicef’s national committees collected funds for Unicef programs for vaccinating children in developing countries against six common children’s infectious diseases. At the auction at the National Gallery, Lek adopted four dolls, including the most expensive doll which was designed by Dada Volk, for SIT 80,000.
6. 4. 2005 |
On the Health Day, Lek, a Sandoz company, donated funds to the Slovenian Heart Foundation for the purchase of two defibrillators which can automatically restart a heart beat and can be used by laymen. The Slovenian Heart Foundation is attempting to place the automatic defibrillators in public places throughout Slovenia. With this, Lek is improving the survival of heart attack victims.
31. 5. 2005 |
The campaign, which for over 20 years has achieved internationally enviable results in the oral health of children, is organized by the Stomatology Section of the Slovenian Medical Association, in cooperation with the general sponsor Lek. Children who had been taking care of their oral hygiene for the whole year received a symbolic award at regional events and Lek awarded those ranked at the top with a trip.
Lek's newspaper Kolektiv and Bulletin are the best in Slovenia
1. 6. 2005 |
For the fifth consecutive year, a working group of reporters in companies and institutions that operate within the Slovene Association of Journalists selected the best internal newspapers of companies at an honorary award ceremony. For the best internal newspaper, bulletin and electronic newspaper in Slovenia, it selected Lek’s newspaper Kolektiv, electronic Kolektiv and the Bulletin. The Golden Pen for all three categories was a joint award to all the employees, especially to members of the editorial committee who, through regular contributions in co-creating the Bulletin and the Kolektiv, contribute to better communication with employees.
15. 6. 2005 |
The Chamber of Commerce and Industry of Slovenia, the Regional Chamber of Ljubljana, presented a gold award with a certificate for the innovation ‘Development of the original technological process for the production of pallets’ to the pharmaceutical company Lek and the authors Bojan Kofler, Barbara Rebič, Judita Širca, Dr. Peter Venturini, Nataša Hafner Malič and Dr. Anton Ćopar. Lek’s inventors developed a technology which enables the safe passing of acid sensitive active ingredients, such as Omeprozole, through the stomach and allows for its fast release in the small intestine.
23. 6. 2005 |
The Jožef Stefan Institute gave the pharmaceutical company Lek, a Sandoz company, its honorary certificate for a successful scientific and technological cooperation. At the same time, it also gave personal awards for cooperation in research, which were received by Janja Bratoš, CEO of Lek, Dr Brina Ornik, executive director of Research and Development at Lek, and Prof. Dr. Uroš Urleb, an executive director for Active Ingredient Research at Lek.
6. 7. 2005 |
At its meeting on July 6, the Supervisory Board of Lek, a Sandoz company, appointed Ksenija Butenko Černe as its new member for the management and legal compliance of Lek, a socially responsible company. At the end of July, the Lek Shareholders Assembly also appointed two new members to the Lek Supervisory board, Dr. Andreas Strüngmann and Markus Delfosse.
14. 7. 2005 |
In the first six months of 2005, Lek, a Sandoz company, recorded $ 352.1 million in sales, which is 8% higher than in the same period of the previous year. Between markets, the sales in western Europe, USA and overseas countries were 29.6%; in central and eastern Europe, including the CIS countries they were at 58.5%, and on the national Slovenian market they were 11.9%. Lek has a balanced sales market structure which allows us to attain the optimal utilization of product potentials which are intended for global sales. The USA remains Lek’s leading market.
Lek is the main sponsor of Luka Špik
29. 8. 2005 |
For the sponsorship of the Olympic Committee of Slovenia, with whom we have participated since 1995, we concluded a contract for the main sponsorship with the Olympic medalist Luka Špik on August 28. We are striving together to encourage sport’s activity and healthy living of individuals and society.
21. 10. 2005 |
Lek, a Sandoz company, opened a plant in Mengeš for the final operations in the manufacturing of hypolipemic active ingredients, where Lek will produce the finished form of the active ingredients for pharmaceutical products, and for medicine reducing cholesterol levels and serum lipids. Lek will supply these active ingredients to the whole Sandoz group, the generic division of Novartis.
25. 11. 2005 |
Lek, a Sandoz company, opened a new plant at its Lendava site for the final isolation phases of potassium clavulanate, which is the key ingredient of Amoxiclav, one of leading products of Lek and Sandoz. On this occasion, Lek also marked 20 years of successful production of pharmaceutical active ingredients in Lendava.
12. 12. 2005 |
In 2005, Lek, a Sandoz company, continued its social responsibility role by visiting children in all Slovenian hospitals. When developing the campaign, we wanted children to have a better time in hospitals and to stimulate their creativity. We prepared creative workshops for them, furnished children’s corners in hospitals, and gave them a full-year’s subscription to the magazine Petka.